from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2557/-

LFCtreatmentdescriptionclass of inhibitor

1.085

Amikacinug/mL Amikacintranslation

0.716

Cap5-10ug/mL Capreomycintranslation

-0.449

Rox10-50 ug/mL Roxithromycintranslation

-0.657

SM2-5 ug/mL Streptomycintranslation

0.092

Tet5-10 ug/mL Tetracyclinetranslation

-0.587

Rif0.2-5ug/mL Rifampicintranscription

-0.992

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.940

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.563

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.250

CPZ10-50 ug/mL Chlorpromazinerespiration

0.447

Clofazimine10-13 ug/mL Clofaziminerespiration

0.181

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.908

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.008

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.750

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.218

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.216

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.312

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.039

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.460

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.787

KCN5-20 ug/mL Potassium cyaniderespiration

0.235

NaN30.2-2 mM Sodium aziderespiration

0.541

Nigericin50 uM Nigericinrespiration

1.800

TRC10-150 ug/mL Triclosanrespiration

1.320

TRZ10-25 ug/mL Thioridazinerespiration

-0.981

Valinomycin0.5-10 uM Valinomycinrespiration

-0.475

ZnSO42 mM ZnSO4respiration

-0.655

menadione6-10 ug/mL Menadionerespiration

0.192

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.494

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.160

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.525

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.369

NRP_1Non-replicating persistence stage 1dosRassociated

-0.760

Amp0.2mg/mL AmpicillincellWall

-0.718

Cephalexin20-100 ug/mL CephalexincellWall

-0.809

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.281

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.688

EMB10-20 ug/mL EthambutolcellWall

-0.460

Eta12-40 ug/mL EthionamidecellWall

-0.501

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.575

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.728

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.016

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.855

BZA0.12 mg/mL BenzamidearomaticAmides

0.548

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.703

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.963

H2O24 mM hydrogen peroxideDNAdamaging

-0.094

Levo10 ug/mL LevofloxacinDNAdamaging

-0.937

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.141

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.467

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.814

UVUV-irradiationDNAdamaging

1.656

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.135

Antimycin12.5-50 ug/mL Antimycin A?

-0.399

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.534

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.521

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.977

PA8240.2-2 ug/mL PA-824?

0.421

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.426

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.585

Verapamil50 uM Verapamil?

-0.280

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.769

methoxatin10-20 ug/mL Methoxatin?